Skip to main content
/
Xlife Sciences AG (SWX:XLS)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
19.45
-3.05 (-13.56%)
At close: May 2, 2025, 5:20 PM CET

Xlife Sciences AG Revenue

In the year 2024, Xlife Sciences AG had annual revenue of 834.88K CHF, down -15.54%. Xlife Sciences AG had revenue of 485.06K in the half year ending December 31, 2024, a decrease of -26.00%.

Revenue
834.88K
Revenue Growth
-15.54%
P/S Ratio
134.11
Revenue / Employee
49.11K
Employees
17
Market Cap
111.96M

Revenue Chart

Created with Highcharts 11.4.8Xlife Sciences AG Revenue - Annual396.81K​396.81K806.07K​806.07K1.03M​1.03M988.44K​988.44K834.88K​834.88K20202021202220232024-250K500K750K1M

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024834.88K-153.56K-15.54%
Dec 31, 2023988.44K-39.54K-3.85%
Dec 31, 20221.03M221.91K27.53%
Dec 31, 2021806.07K409.26K103.14%
Dec 31, 2020396.81K-118.02K-22.92%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Roche Holding AG 62.40B
Novartis AG 47.05B
Lonza Group AG 6.57B
Alcon 8.98B
Galderma Group AG 4.02B
Straumann Holding AG 2.50B
Sandoz Group AG 9.41B
Sonova Holding AG 3.71B
Revenue Rankings